Massimo Breccia | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS	2017
EPIDEMIOLOGY, OUTCOME AND RISK FACTORS FOR INFECTIOUS COMPLICATIONS IN MF PATIENTS RECEIVING RUXOLITINIB. A MULTICENTER STUDY ON 373 PATIENTS	HAEMATOLOGICA	2017
A REAL-LIFE STUDYOF DEFERASIROX IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROMES	LEUKEMIA RESEARCH	2017
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with <= 30% blasts	LEUKEMIA	2017
Ponatinib: A Review of Efficacy and Safety	CURRENT CANCER DRUG TARGETS	2017
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia	EUROPEAN JOURNAL OF HAEMATOLOGY	2016
Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN	BLOOD	2016
Essential Thrombocythemia: A Comparison of Overall and Thrombosis Free Survival in Two Discrete Periods of the First Decade of 2000. a Retrospective Analysis	BLOOD	2016
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes. a “Gruppo Romano Mielodisplasie (GROM)” multicenter study	ANNALS OF HEMATOLOGY	2016
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response	LEUKEMIA & LYMPHOMA	2016
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients	HAEMATOLOGICA	2016
Incidence of Severe (<= 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy	BLOOD	2016
Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis	BLOOD	2016
Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies	SUPPORTIVE CARE IN CANCER	2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia	LEUKEMIA	2016
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly	BRITISH JOURNAL OF HAEMATOLOGY	2016
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET	HAEMATOLOGICA	2016
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis	SUPPORTIVE CARE IN CANCER	2016
DEFERASIROX IN THE TREATMENT OF IRON OVERLOAD DURING MYELOPROLIFERATIVE NEOPLASMS (MPN)	HAEMATOLOGICA	2016
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia	ANNALS OF HEMATOLOGY	2016